These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31151992)

  • 1. Efficient electroporation of neuronal cells using synthetic oligonucleotides: identifying duplex RNA and antisense oligonucleotide activators of human frataxin expression.
    Shen X; Beasley S; Putman JN; Li Y; Prakash TP; Rigo F; Napierala M; Corey DR
    RNA; 2019 Sep; 25(9):1118-1129. PubMed ID: 31151992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Frataxin Protein Expression by Antisense Oligonucleotides Targeting the Mutant Expanded Repeat.
    Li L; Shen X; Liu Z; Norrbom M; Prakash TP; O'Reilly D; Sharma VK; Damha MJ; Watts JK; Rigo F; Corey DR
    Nucleic Acid Ther; 2018 Feb; 28(1):23-33. PubMed ID: 29341839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards drug discovery for Friedreich's Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein.
    Shen X; Wong J; Prakash TP; Rigo F; Li Y; Napierala M; Corey DR
    Bioorg Med Chem; 2020 Jun; 28(11):115472. PubMed ID: 32279920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting 3' and 5' untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression.
    Li Y; Li J; Wang J; Lynch DR; Shen X; Corey DR; Parekh D; Bhat B; Woo C; Cherry JJ; Napierala JS; Napierala M
    Nucleic Acids Res; 2021 Nov; 49(20):11560-11574. PubMed ID: 34718736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties translating antisense-mediated activation of Frataxin expression from cell culture to mice.
    Kilikevicius A; Wang J; Shen X; Rigo F; Prakash TP; Napierala M; Corey DR
    RNA Biol; 2022; 19(1):364-372. PubMed ID: 35289725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-rich motifs within phosphorothioate-based antisense oligonucleotides (ASOs) drive activation of FXN expression through indirect effects.
    Wang F; Calvo-Roitberg E; Rembetsy-Brown JM; Fang M; Sousa J; Kartje ZJ; Krishnamurthy PM; Lee J; Green MR; Pai AA; Watts JK
    Nucleic Acids Res; 2022 Dec; 50(22):12657-12673. PubMed ID: 36511872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion.
    Shen X; Kilikevicius A; O'Reilly D; Prakash TP; Damha MJ; Rigo F; Corey DR
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2850-2855. PubMed ID: 30076049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells.
    Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA
    Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.
    Crombie DE; Curl CL; Raaijmakers AJ; Sivakumaran P; Kulkarni T; Wong RC; Minami I; Evans-Galea MV; Lim SY; Delbridge L; Corben LA; Dottori M; Nakatsuji N; Trounce IA; Hewitt AW; Delatycki MB; Pera MF; Pébay A
    Aging (Albany NY); 2017 May; 9(5):1440-1452. PubMed ID: 28562313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frataxin deficiency alters gene expression in Friedreich ataxia derived IPSC-neurons and cardiomyocytes.
    Angulo MB; Bertalovitz A; Argenziano MA; Yang J; Patel A; Zesiewicz T; McDonald TV
    Mol Genet Genomic Med; 2023 Jan; 11(1):e2093. PubMed ID: 36369844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SINEUP non-coding RNAs rescue defective frataxin expression and activity in a cellular model of Friedreich's Ataxia.
    Bon C; Luffarelli R; Russo R; Fortuni S; Pierattini B; Santulli C; Fimiani C; Persichetti F; Cotella D; Mallamaci A; Santoro C; Carninci P; Espinoza S; Testi R; Zucchelli S; Condò I; Gustincich S
    Nucleic Acids Res; 2019 Nov; 47(20):10728-10743. PubMed ID: 31584077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining Transcription Regulatory Elements in the Human Frataxin Gene: Implications for Gene Therapy.
    Li J; Li Y; Wang J; Gonzalez TJ; Asokan A; Napierala JS; Napierala M
    Hum Gene Ther; 2020 Aug; 31(15-16):839-851. PubMed ID: 32527155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes.
    Li J; Rozwadowska N; Clark A; Fil D; Napierala JS; Napierala M
    Stem Cell Res; 2019 Oct; 40():101529. PubMed ID: 31446150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activating frataxin expression by repeat-targeted nucleic acids.
    Li L; Matsui M; Corey DR
    Nat Commun; 2016 Feb; 7():10606. PubMed ID: 26842135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected Histone Deacetylase Inhibitors Reverse the Frataxin Transcriptional Defect in a Novel Friedreich's Ataxia Induced Pluripotent Stem Cell-Derived Neuronal Reporter System.
    Schreiber AM; Li Y; Chen YH; Napierala JS; Napierala M
    Front Neurosci; 2022; 16():836476. PubMed ID: 35281493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature transcription termination at the expanded GAA repeats and aberrant alternative polyadenylation contributes to the Frataxin transcriptional deficit in Friedreich's ataxia.
    Li Y; Li J; Wang J; Zhang S; Giles K; Prakash TP; Rigo F; Napierala JS; Napierala M
    Hum Mol Genet; 2022 Oct; 31(20):3539-3557. PubMed ID: 35708503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotides Hold Promise as a Therapy for Friedreich's Ataxia: Friedreich's ataxia currently is incurable, but synthetic antisense oligonucleotides have demonstrated promising results in increasing frataxin gene expression and restoring it to normal levels.
    Am J Med Genet A; 2018 Jun; 176(6):1282. PubMed ID: 29878710
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA repair pathways are altered in neural cell models of frataxin deficiency.
    Moreno-Lorite J; Pérez-Luz S; Katsu-Jiménez Y; Oberdoerfer D; Díaz-Nido J
    Mol Cell Neurosci; 2021 Mar; 111():103587. PubMed ID: 33418083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
    Polak U; Li Y; Butler JS; Napierala M
    Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.
    Lai JI; Nachun D; Petrosyan L; Throesch B; Campau E; Gao F; Baldwin KK; Coppola G; Gottesfeld JM; Soragni E
    J Biol Chem; 2019 Feb; 294(6):1846-1859. PubMed ID: 30552117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.